Lenacapavir long-acting Clinical Trials
3 recruitingDrug
Phase 42Not Applicable1
Showing 1–3 of 3 trials
Recruiting
Not Applicable
ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
Contact With or Exposure to Human Immunodeficiency Virus
Oswaldo Cruz Foundation1,500 enrolled8 locationsNCT07497594
Recruiting
Phase 4
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
HIV Prevention
Duke University100 enrolled1 locationNCT07218211
Recruiting
Phase 4
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
HIV
Kelley-Ross & Associates, Inc.75 enrolled1 locationNCT07210125